What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.
Ohio State Researchers Cross Disciplines to Establish National STOP-COVID Center
Vaccines, Free Full-Text
Cancer Researchers Combat COVID-19, COVID and Cancer Report
Will cancer vaccines change the way we treat cancer?
Characterization of nanoparticles-based vaccines for COVID-19
Research Spotlight - Kaiser Permanente Division of Research
National Cancer Institute Thesaurus (NCIt)
COVID-19 and Cancer: a Comprehensive Review
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants
Antiviral drug discovery: preparing for the next pandemic - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D0CS01118E
NCI's Research on COVID-19, Vaccines, and Antibodies - NCI
Antibodies and Vaccines as Drugs for COVID-19, keystone symposia
Antibodies and Vaccines as Drugs for COVID-19, keystone symposia